IFN

BIOLOGICAL2 trials

Sponsors

The Cleveland Clinic, Dartmouth-Hitchcock Medical Center

Conditions

Breast CancerKidney CancerLymphomaMelanomaMetastatic Renal Cell CarcinomaMultiple MyelomaSarcomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

CompletedNCT00276536

The Cleveland ClinicBreast Cancer, Kidney Cancer, Lymphoma +4

Start: 2001-01-31End: 2004-01-31Updated: 2015-10-14

Phase 2

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

TerminatedNCT00913913

Dartmouth-Hitchcock Medical CenterMetastatic Renal Cell Carcinoma

Start: 2009-02-28End: 2013-01-31Updated: 2015-12-01